Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 3 1

Status

Completed 15Unknown 11Recruiting 6Terminated 4Not yet recruiting 3Withdrawn 1Active not recruiting 1

Sponsor Class

OTHER 5INDUSTRY 1

Study Type

Interventional 5Observational 1

Sponsor

Cancer Type

Gastrointestinal 26Breast 16Thoracic 6Head & Neck 6Gynecologic 6Sarcoma 4Genitourinary 4Tumor-Agnostic 2Lymphoid 2Plasma cell 1Endocrine 1

Conditions

Carcinoma, Non-Small-Cell Lung 4Lung Neoplasms 2Parkinson Disease 4, Autosomal Dominant Lewy Body 1Neoadjuvant Therapy 1

Interventions

Carboplatin 181pembrolizumab 156Pemetrexed 129Cisplatin 97Drug Therapy 67Paclitaxel 59osimertinib 56Magnetic Resonance Spectroscopy 50durvalumab 49Specimen Handling 49Radiotherapy 49Nivolumab 49atezolizumab 43Docetaxel 43Etoposide 40Bevacizumab 39Blood Specimen Collection 33tislelizumab 31Radiosurgery 31Gemcitabine 29130-nm albumin-bound paclitaxel 27Immunotherapy 25Immune Checkpoint Inhibitors 25cemiplimab 23Injections 23aflutinib 20Cetuximab 18Biopsy 18Standard of Care 17Platinum Compounds 17

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Recruiting × Neoadjuvant Therapy × Thoracic × Clear all
NCT06788912 2026-06-01

MK-3475-01E

Merck Sharp & Dohme LLC

Phase 2 Recruiting
60 enrolled
Thoracic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Lung Neoplasms

NCT07103395 2026-01-14

A Study Evaluating Neoadjuvant Chemotherapy, Concurrent Chemoradiotherapy Combined With Dual Immune Checkpoint Blockade in Patients With Locally Advanced Non-Small Cell Lung Cancer

Sun Yat-sen University

Phase 2 Recruiting
56 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07084610 2025-08-22

Metabolic Biomarkers Predicting Response to Neoadjuvant Immunotherapy in Non-Small Cell Lung Cancer

Hospital das Clínicas de Ribeirão Preto

Phase 2 Recruiting
30 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT06734702 2025-07-24

Neoadjuvant Immunotherapy Plus Chemotherapy Followed by Concurrent Chemoradiotherapy and Consolidative Immunotherapy for Locally Advanced Non-small Cell Lung Cancer

Sun Yat-sen University

Phase 3 Recruiting
497 enrolled
Thoracic

Neoadjuvant Therapy

NCT04875585 2022-08-24

INNWOP1

Medical University Innsbruck

Phase 2 Recruiting
33 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04926584 2022-08-16

KOMPASSneo

Klinikum Esslingen

Recruiting
50 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡